Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Status:
Completed
Trial end date:
2016-09-09
Target enrollment:
Participant gender:
Summary
This study is a Phase 1, single-center, open-label, ascending dose study which will assess
the safety and tolerability of 5 doses of spray-dried solvent/detergent treated plasma
(Resusix®) in healthy volunteers.